Literature DB >> 22461326

Inherited deleterious variants in GALNT12 are associated with CRC susceptibility.

Erica Clarke1, Roger C Green, Jane S Green, Krista Mahoney, Patrick S Parfrey, H Banfield Younghusband, Michael O Woods.   

Abstract

A recent report detailed the occurrence of both somatic and constitutional variants in the GALNT12 gene, located at 9q22.33, in some colorectal cancer (CRC) patients. In this study, we investigate the occurrence of inherited deleterious variants in GALNT12 in 118 families referred to a cancer genetics clinic. We discovered two deleterious variants (c.907G>A (p.Asp303Asn); c.1187A>G (p.Tyr396Cys)) in 4/118 probands. The variants, which were not found in 149 control individuals (P = 0.0376), cosegregate with CRC and/or adenomatous polyps in other family members. The probability by chance that cosegregation of c.907G>A with CRC and/or adenomatous polyps occurred, in the two pedigrees combined, was 1.56%. Although this study does not provide irrefutable evidence that GALNT12 variants are highly penetrant alleles that predispose to CRC in the majority of unexplained hereditary CRC families, it does provide additional evidence to support an important role of these variants in a proportion of this considerable high-risk group.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22461326     DOI: 10.1002/humu.22088

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  23 in total

1.  Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC).

Authors:  Rosa M Xicola; Sneha Bontu; Brian J Doyle; Jamie Rawson; Pilar Garre; Esther Lee; Miguel de la Hoya; Xavier Bessa; Joan Clofent; Luis Bujanda; Francesc Balaguer; Sergi Castellví-Bel; Cristina Alenda; Rodrigo Jover; Clara Ruiz-Ponte; Sapna Syngal; Montserrat Andreu; Angel Carracedo; Antoni Castells; Polly A Newcomb; Noralane Lindor; John D Potter; John A Baron; Nathan A Ellis; Trinidad Caldes; Xavier LLor
Journal:  Carcinogenesis       Date:  2016-05-27       Impact factor: 4.944

2.  Altered glycosyltransferases in colorectal cancer.

Authors:  Srividya Venkitachalam; Kishore Guda
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2016-11-04       Impact factor: 3.869

Review 3.  Multi-Gene Panel Testing in Gastroenterology: Are We Ready for the Results?

Authors:  Flávio Pereira; Manuel R Teixeira; Mário Dinis Ribeiro; Catarina Brandão
Journal:  GE Port J Gastroenterol       Date:  2021-02-04

Review 4.  New genes emerging for colorectal cancer predisposition.

Authors:  Clara Esteban-Jurado; Pilar Garre; Maria Vila; Juan José Lozano; Anna Pristoupilova; Sergi Beltrán; Anna Abulí; Jenifer Muñoz; Francesc Balaguer; Teresa Ocaña; Antoni Castells; Josep M Piqué; Angel Carracedo; Clara Ruiz-Ponte; Xavier Bessa; Montserrat Andreu; Luis Bujanda; Trinidad Caldés; Sergi Castellví-Bel
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

Review 5.  Incorporating Colorectal Cancer Genetic Risk Assessment into Gastroenterology Practice.

Authors:  Benjamin Stern; Thomas McGarrity; Maria Baker
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

Review 6.  Familial colorectal cancer type X: genetic profiles and phenotypic features.

Authors:  Mev Dominguez-Valentin; Christina Therkildsen; Sabrina Da Silva; Mef Nilbert
Journal:  Mod Pathol       Date:  2014-04-18       Impact factor: 7.842

Review 7.  The Cosmc connection to the Tn antigen in cancer.

Authors:  Tongzhong Ju; Rajindra P Aryal; Matthew R Kudelka; Yingchun Wang; Richard D Cummings
Journal:  Cancer Biomark       Date:  2014-01-01       Impact factor: 4.388

8.  Evidence for GALNT12 as a moderate penetrance gene for colorectal cancer.

Authors:  Daniel R Evans; Srividya Venkitachalam; Leslie Revoredo; Amanda T Dohey; Erica Clarke; Julia J Pennell; Amy E Powell; Erina Quinn; Lakshmeswari Ravi; Thomas A Gerken; Jane S Green; Michael O Woods; Kishore Guda
Journal:  Hum Mutat       Date:  2018-05-28       Impact factor: 4.878

9.  Large numbers of individuals are required to classify and define risk for rare variants in known cancer risk genes.

Authors:  Brian H Shirts; Angela Jacobson; Gail P Jarvik; Brian L Browning
Journal:  Genet Med       Date:  2013-12-19       Impact factor: 8.822

10.  Genetic Predisposition to Numerous Large Ulcerating Basal Cell Carcinomas and Response to Immune Therapy.

Authors:  Bahar Dasgeb; Youssefian Leila; Amir Hossein Saeidian; Jun Kang; Wenyin Shi; Elizabeth Shoenberg; Adam Ertel; Paolo Fortina; Hassan Vahidnezhad; Jouni Uitto
Journal:  Int J Dermatol Venereol       Date:  2021-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.